These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 17914416

  • 1. Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: the need for randomized trials.
    Al-Aly Z.
    Kidney Int; 2007 Oct; 72(8):909-11. PubMed ID: 17914416
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D levels and early mortality among incident hemodialysis patients.
    Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA, Tonelli M, Thadhani R.
    Kidney Int; 2007 Oct; 72(8):1004-13. PubMed ID: 17687259
    [Abstract] [Full Text] [Related]

  • 3. [Vitamin D, cardiovascular disease and mortality in patients with kidney disease].
    Hansen D, Brandi L, Rasmussen K.
    Ugeskr Laeger; 2009 Dec 07; 171(50):3684-9. PubMed ID: 20003863
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D supplementation in CKD.
    Martin KJ, González EA.
    Clin Nephrol; 2011 Apr 07; 75(4):286-93. PubMed ID: 21426882
    [Abstract] [Full Text] [Related]

  • 5. [Vitamin D deficiency in kidney failure. Risk factor for cardiovascular disease].
    Ohman K, Larsson T, Spaak J.
    Lakartidningen; 2011 Apr 07; 107(46):2884-7. PubMed ID: 21197784
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives.
    Drüeke TB, Ritz E.
    Clin J Am Soc Nephrol; 2009 Jan 07; 4(1):234-41. PubMed ID: 19056615
    [Abstract] [Full Text] [Related]

  • 7. Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients.
    Shireman TI, Almehmi A, Wetmore JB, Lu J, Pregenzer M, Quarles LD.
    Am J Kidney Dis; 2010 Dec 07; 56(6):1108-16. PubMed ID: 20951487
    [Abstract] [Full Text] [Related]

  • 8. Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease.
    Wolf M, Thadhani R.
    Semin Dial; 2005 Dec 07; 18(4):302-6. PubMed ID: 16076353
    [Abstract] [Full Text] [Related]

  • 9. Use (or misuse) of vitamin D treatment in CKD and dialysis patients: A recent meta-analysis on vitamin D compounds in chronic kidney disease [1] and an editorial comment [2] accompanying this meta-analysis have already been published. We believe that these papers deserve some comments in the interest of the NDT readership.
    Olgaard K, Lewin E.
    Nephrol Dial Transplant; 2008 Jun 07; 23(6):1786-9; discussion 1789-3. PubMed ID: 18400819
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. When is Vitamin D contraindicated in dialysis patients?
    Evenepoel P.
    Semin Dial; 2009 Jun 07; 22(3):242-4. PubMed ID: 19572999
    [No Abstract] [Full Text] [Related]

  • 12. Challenges in the therapy of secondary hyperparathyroidism.
    Wood C, González EA, Martin KJ.
    Ther Apher Dial; 2005 Feb 07; 9(1):4-8. PubMed ID: 15828898
    [Abstract] [Full Text] [Related]

  • 13. When is Vitamin D contraindicated in dialysis patients?
    Khosla N, Sprague SM.
    Semin Dial; 2009 Feb 07; 22(3):249-51. PubMed ID: 19573002
    [No Abstract] [Full Text] [Related]

  • 14. When is Vitamin D Contraindicated in Dialysis Patients?
    Goodman WG.
    Semin Dial; 2009 Feb 07; 22(3):245-7. PubMed ID: 19573000
    [No Abstract] [Full Text] [Related]

  • 15. When is Vitamin D contraindicated in dialysis patients?
    Martin KJ.
    Semin Dial; 2009 Feb 07; 22(3):247-9. PubMed ID: 19573001
    [No Abstract] [Full Text] [Related]

  • 16. [Vitamin D and survival of hemodialysis patients].
    Shoji T, Nishizawa Y.
    Clin Calcium; 2004 Sep 07; 14(9):64-8. PubMed ID: 15577113
    [Abstract] [Full Text] [Related]

  • 17. Assessing the effect of oral activated vitamin D on overall survival in hemodialysis patients: a landmark analysis.
    Chao JY, Chien HC, Kuo TH, Chang YT, Li CY, Wang MC, Kao Yang YH.
    BMC Nephrol; 2018 Nov 06; 19(1):309. PubMed ID: 30400889
    [Abstract] [Full Text] [Related]

  • 18. Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified.
    Ix JH, Quarles LD, Chertow GM.
    Nat Clin Pract Nephrol; 2006 Jun 06; 2(6):337-9. PubMed ID: 16932455
    [Abstract] [Full Text] [Related]

  • 19. The dual vitamin D pathways: considerations for adequate supplementation.
    Cronin SC.
    Nephrol Nurs J; 2010 Jun 06; 37(1):19-26, 36; quiz 27-8. PubMed ID: 20333900
    [Abstract] [Full Text] [Related]

  • 20. Paricalcitol, a new agent for the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis.
    Goldenberg MM.
    Clin Ther; 1999 Mar 06; 21(3):432-41. PubMed ID: 10321413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.